Collplant Biotechnologies Ltd ADR (CLGN)

$1.89 -0.02 (-0.84%)
Market Cap 24.35M
Revenue (ttm) 520,000.00
Net Income (ttm) -16.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,194.23%
Debt to Equity Ratio 0.00
Volume 13,900
Avg Vol 28,892
Day's Range N/A - N/A
Shares Out 12.78M
Stochastic %K 83%
Beta 1.47
Analysts Strong Sell
Price Target $11.50

Company Profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matri...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 73 232 5600
Fax: 972 73 232 5602
Address:
Weizmann Science Park, 4 Oppenheimer P.O. Box 4132, Rehovot, Israel
Al144
Al144 Jan. 28 at 1:27 AM
$CLGN Guys, who are experts in the sector, does the company have any independent positive prospects other than selling to a major player?
0 · Reply
peepthestamp
peepthestamp Jan. 24 at 2:04 AM
$CLGN
0 · Reply
Victory777777
Victory777777 Jan. 23 at 7:35 PM
Welcome 🤗 to $GORO $CLGN $GORO $GTEC $RVYL
0 · Reply
dln101
dln101 Jan. 23 at 5:17 PM
$CLGN time for the next 100% for this kow floater similar to $KUST $DRCT $MOVE 🤔💪🔥🍾
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 31 at 9:48 PM
$CLGN Share Price: $1.40 Contract Selected: Jul 17, 2026 $2.5 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 54% ROI Time to Expiration: 197 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
topstockalerts
topstockalerts Dec. 30 at 1:00 PM
Pre Market Top Gainers PT2 $FONR $CLGN $GRI $GRDX.X $CIGL
0 · Reply
PlateauPipsV2
PlateauPipsV2 Dec. 27 at 4:56 AM
$CLGN Risk tolerance remains selective and tied closely to execution credibility. Margins must hold as the company navigates cost pressure. Missteps now carry a higher penalty than in prior cycles. Without validation, volatility may persist longer than expected.
0 · Reply
dln101
dln101 Dec. 18 at 3:23 PM
$CLGN helthacre low floater double bottom bounce potential here 🤔 to $LONA $NBY levels 💪🔥🚀
0 · Reply
prismmarketview
prismmarketview Nov. 28 at 3:10 PM
CollPlant $CLGN updates Q3 results, strengthening its cash runway and expanding U.S. infrastructure as its aesthetics and BioInk programs move forward. https://prismmarketview.com/collplant-strengthens-cash-runway-and-expands-u-s-infrastructure-as-aesthetics-and-bioink-pipeline-advances/
0 · Reply
DARKP00L
DARKP00L Nov. 28 at 2:28 PM
$CLGN 09:06 on Nov. 28 2025 D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target #tradeideas
0 · Reply
Latest News on CLGN
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Nov 26, 2025, 7:30 AM EST - 2 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

Nov 18, 2025, 7:00 AM EST - 2 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

Oct 27, 2025, 7:01 AM EDT - 3 months ago

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

Oct 20, 2025, 7:00 AM EDT - 3 months ago

CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

Oct 16, 2025, 7:00 AM EDT - 3 months ago

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

Sep 30, 2025, 7:00 AM EDT - 4 months ago

CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

CollPlant Expands the Distribution of its VergenixSTR Product in Europe

Sep 15, 2025, 7:00 AM EDT - 4 months ago

CollPlant Expands the Distribution of its VergenixSTR Product in Europe

CollPlant to Present at the 2025 International Conference on Biofabrication

Sep 2, 2025, 7:00 AM EDT - 5 months ago

CollPlant to Present at the 2025 International Conference on Biofabrication

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

Aug 25, 2025, 7:00 AM EDT - 5 months ago

CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Aug 20, 2025, 7:00 AM EDT - 5 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

Aug 5, 2025, 7:00 AM EDT - 6 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

Jul 14, 2025, 7:00 AM EDT - 7 months ago

CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

Jun 9, 2025, 7:00 AM EDT - 8 months ago

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

Jun 4, 2025, 7:00 AM EDT - 8 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

May 30, 2025, 7:00 AM EDT - 8 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

May 28, 2025, 7:00 AM EDT - 8 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

May 14, 2025, 7:00 AM EDT - 9 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies

Apr 15, 2025, 8:00 AM EDT - 10 months ago

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies

CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 7:58 PM EDT - 11 months ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

Mar 26, 2025, 8:00 AM EDT - 11 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

SSYS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Mar 19, 2025, 7:00 AM EDT - 11 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

Feb 24, 2025, 7:00 AM EST - 1 year ago

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

CollPlant Biotechnologies Provides a Corporate Update

Feb 12, 2025, 6:00 AM EST - 1 year ago

CollPlant Biotechnologies Provides a Corporate Update

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

Nov 27, 2024, 11:36 AM EST - 1 year ago

CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Nov 27, 2024, 7:00 AM EST - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Nov 12, 2024, 7:00 AM EST - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

Aug 20, 2024, 6:59 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Aug 20, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

SSYS

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

Aug 19, 2024, 8:30 AM EDT - 1 year ago

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

SSYS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION

Aug 6, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report

Jul 29, 2024, 7:00 AM EDT - 1 year ago

CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report

CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data

Jun 6, 2024, 7:00 AM EDT - 1 year ago

CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data

CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript

May 29, 2024, 12:02 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript

CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update

May 29, 2024, 7:00 AM EDT - 1 year ago

CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

May 16, 2024, 7:00 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript

Apr 4, 2024, 1:15 PM EDT - 1 year ago

CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Apr 4, 2024, 7:17 AM EDT - 1 year ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Mar 26, 2024, 8:00 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Issues Letter to Shareholders

Feb 15, 2024, 8:00 AM EST - 2 years ago

CollPlant Issues Letter to Shareholders

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

Jan 8, 2024, 7:18 AM EST - 2 years ago

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

Jan 2, 2024, 7:00 AM EST - 2 years ago

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

CollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call Transcript

Nov 29, 2023, 2:21 PM EST - 2 years ago

CollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call Transcript

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

Nov 29, 2023, 7:00 AM EST - 2 years ago

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Nov 9, 2023, 8:00 AM EST - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

Nov 1, 2023, 7:05 AM EDT - 2 years ago

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative

Sep 21, 2023, 7:00 AM EDT - 2 years ago

CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative

CollPlant to Present at the H.C. Wainwright Annual Growth Conference

Sep 5, 2023, 7:00 AM EDT - 2 years ago

CollPlant to Present at the H.C. Wainwright Annual Growth Conference

CollPlant Biotechnologies Ltd. (CLGN) Q2 2023 Earnings Call Transcript

Aug 24, 2023, 11:27 PM EDT - 2 years ago

CollPlant Biotechnologies Ltd. (CLGN) Q2 2023 Earnings Call Transcript

CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million

Aug 24, 2023, 7:00 AM EDT - 2 years ago

CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Aug 9, 2023, 9:02 AM EDT - 2 years ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Al144
Al144 Jan. 28 at 1:27 AM
$CLGN Guys, who are experts in the sector, does the company have any independent positive prospects other than selling to a major player?
0 · Reply
peepthestamp
peepthestamp Jan. 24 at 2:04 AM
$CLGN
0 · Reply
Victory777777
Victory777777 Jan. 23 at 7:35 PM
Welcome 🤗 to $GORO $CLGN $GORO $GTEC $RVYL
0 · Reply
dln101
dln101 Jan. 23 at 5:17 PM
$CLGN time for the next 100% for this kow floater similar to $KUST $DRCT $MOVE 🤔💪🔥🍾
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 31 at 9:48 PM
$CLGN Share Price: $1.40 Contract Selected: Jul 17, 2026 $2.5 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 54% ROI Time to Expiration: 197 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
topstockalerts
topstockalerts Dec. 30 at 1:00 PM
Pre Market Top Gainers PT2 $FONR $CLGN $GRI $GRDX.X $CIGL
0 · Reply
PlateauPipsV2
PlateauPipsV2 Dec. 27 at 4:56 AM
$CLGN Risk tolerance remains selective and tied closely to execution credibility. Margins must hold as the company navigates cost pressure. Missteps now carry a higher penalty than in prior cycles. Without validation, volatility may persist longer than expected.
0 · Reply
dln101
dln101 Dec. 18 at 3:23 PM
$CLGN helthacre low floater double bottom bounce potential here 🤔 to $LONA $NBY levels 💪🔥🚀
0 · Reply
prismmarketview
prismmarketview Nov. 28 at 3:10 PM
CollPlant $CLGN updates Q3 results, strengthening its cash runway and expanding U.S. infrastructure as its aesthetics and BioInk programs move forward. https://prismmarketview.com/collplant-strengthens-cash-runway-and-expands-u-s-infrastructure-as-aesthetics-and-bioink-pipeline-advances/
0 · Reply
DARKP00L
DARKP00L Nov. 28 at 2:28 PM
$CLGN 09:06 on Nov. 28 2025 D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Nov. 28 at 2:06 PM
D. Boral Capital updates rating for CollPlant Biotechnologies ( $CLGN ) to Buy, target set at 12.
0 · Reply
mikesterz7
mikesterz7 Nov. 26 at 4:23 PM
$CLGN The firm reported revenue of $77,000 for the three months ended September, above the $4,000 reported in the corresponding quarter of 2024, but below an analyst estimate of $5.03 million, according to data from Fiscal AI.
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 26 at 3:52 PM
CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention $CLGN https://stocktwits.com/news/equity/markets/clgn-stock-crashes-disappointing-earnings-workforce-reduction-plan-draws-investor-attention/cL53AMUREWV
0 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 1:27 PM
D. Boral Capital updates rating for CollPlant Biotechnologies ( $CLGN ) to Buy, target set at 12.
0 · Reply
Tom678
Tom678 Oct. 20 at 11:15 AM
$CLGN another good news
0 · Reply
Johfad54
Johfad54 Oct. 17 at 12:00 PM
$CLGN Someone buy this pls, need to sell
0 · Reply
Tom678
Tom678 Oct. 16 at 11:24 AM
$CLGN amazing news , buying here
0 · Reply
Johfad54
Johfad54 Oct. 16 at 11:10 AM
$CLGN How is there only 2 people here lol
0 · Reply
SEVENXStheGOAT
SEVENXStheGOAT Oct. 16 at 11:07 AM
$CLGN First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
0 · Reply
Mfg0331
Mfg0331 Oct. 3 at 10:42 AM
$CLGN this sht is dead wasted my time and money
0 · Reply
WhatsUpWhatsNot
WhatsUpWhatsNot Oct. 2 at 7:48 PM
$AMPG and $CLGN vs $TSLA today ..no brainer..
0 · Reply